Table 2.

Future clinical implications of molecular genetic findings in fibromyalgia

Subgrouping of fibromyalgia patients

Pharmacologic treatment based on knowledge of patient's genotype

• Subjects with the short 5-HTTLPR allele may be more suitable candidates for antidepressant medication

• Subjects without the 7DRD4 allele may be candidates for dopaminergic medication